Sign Up to like & get
recommendations!
0
Published in 2021 at "European Journal of Immunology"
DOI: 10.1002/eji.202049072
Abstract: Heterologous polyclonal antibodies might represent an alternative to the use of convalescent plasma or monoclonal antibodies (mAbs) in coronavirus disease (COVID‐19) by targeting multiple antigen epitopes. However, heterologous antibodies trigger human natural xenogeneic antibody responses…
read more here.
Keywords:
glyco humanized;
humanized polyclonal;
sars cov;
polyclonal antibodies ... See more keywords